A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes

This publication has 30 references indexed in Scilit:

• CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1998
• Megakaryocyte progenitors derived from bone marrow or G‐CSF‐mobilized peripheral blood CD34⁺ cells show a distinct phenotype and responsiveness to interleukin‐3 (IL‐3) and PEG‐recombinant human megakaryocyte growth and development factor (PEG‐rHuMGDF)
  British Journal of Haematology, 1998
• Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1997
• Effects of Recombinant Human Thrombopoietin Alone and in Combination with Erythropoietin and Early‐Acting Cytokines on Human Mobilized Purified CD34 ⁺ Progenitor Cells Cultured in Serum‐Depleted Medium
  The International Journal of Cell Cloning, 1997
• Cloning and Characterization of the Human Megakaryocyte Growth and Development Factor (MGDF) Gene
  Published by Elsevier ,1995
• Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI
  Cell, 1994
• c-Mpl ligand is a humoral regulator of megakaryocytopoiesis
  Nature, 1994
• Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
  Nature, 1994
• Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
  Nature, 1994
• Interleukin-1: Biological Effects in Human Hematopoiesis
  Leukemia & Lymphoma, 1993